Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Alexandre Cavalcanti and Phillip Scheinberg.
Alexandre Cavalcanti
Connection Strength
0.113
Phillip Scheinberg
  1. Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial. BMJ. 2021 01 20; 372:n84.
    View in: PubMed
    Score: 0.058
  2. Rationale and design of the "Tocilizumab in patients with moderate to severe COVID-19: an open-label multicentre randomized controlled" trial (TOCIBRAS). Rev Bras Ter Intensiva. 2020 Jul-Sep; 32(3):337-347.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.